RecruitingNot ApplicableNCT07056244

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block

Dexmedetomidine Versus Dexamethasone as Adjuvants to Bupivacaine in Caudal Epidural Block for Pediatrics Undergoing Inguinal Hernia Surgery: A Comparative Prospective Double-Blind Randomized Clinical Trial


Sponsor

Sohag University

Enrollment

80 participants

Start Date

Jun 13, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of This prospective, randomized, double-blind comparative study is to compare the efficacy of dexamethasone and dexmedetomidine as adjuvants to bupivacaine 0.125% in caudal epidural block for pediatrics undergoing inguinal hernia surgery, aged 2-6 years. of Both sex.


Eligibility

Min Age: 2 YearsMax Age: 6 Years

Inclusion Criteria4

  • Children aged 2-6 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I and II.
  • Scheduled for inguinal hernia surgery

Exclusion Criteria7

  • Parents or legal guardians refusal.
  • Known hypersensitivity to any study drugs.
  • Abnormal sacral anatomy
  • Local infection at the injection site.
  • Neurological disease.
  • Coagulopathy.
  • Mental retardation.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

as adjuvant to bupivacaine in caudal epidural block for postoperative analgesia

DRUGDexamethasone

as adjuvant to bupivacaine in caudal epidural block for postoperative analgesia


Locations(1)

Sohag university Hospital

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07056244


Related Trials